↓ Skip to main content

Cochrane Database of Systematic Reviews

Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing…

Overview of attention for article published in Cochrane database of systematic reviews, November 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
2 tweeters
facebook
1 Facebook page
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
217 Mendeley
Title
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
Published in
Cochrane database of systematic reviews, November 2011
DOI 10.1002/14651858.cd008872.pub2
Pubmed ID
Authors

Alexandra N Colebatch, Jonathan L Marks, Christopher J Edwards

Abstract

Methotrexate is routinely used in the treatment of inflammatory arthritis. There have been concerns regarding the safety of using concurrent non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, or paracetamol (acetaminophen), or both, in these people.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 <1%
United States 2 <1%
Chile 1 <1%
Brazil 1 <1%
Australia 1 <1%
Sri Lanka 1 <1%
United Kingdom 1 <1%
Unknown 208 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 37 17%
Student > Master 36 17%
Student > Bachelor 28 13%
Student > Ph. D. Student 23 11%
Other 12 6%
Other 35 16%
Unknown 46 21%
Readers by discipline Count As %
Medicine and Dentistry 90 41%
Nursing and Health Professions 17 8%
Pharmacology, Toxicology and Pharmaceutical Science 16 7%
Psychology 9 4%
Agricultural and Biological Sciences 7 3%
Other 26 12%
Unknown 52 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2022.
All research outputs
#1,752,234
of 21,749,791 outputs
Outputs from Cochrane database of systematic reviews
#3,986
of 12,101 outputs
Outputs of similar age
#10,784
of 149,970 outputs
Outputs of similar age from Cochrane database of systematic reviews
#15
of 77 outputs
Altmetric has tracked 21,749,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,101 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 149,970 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.